The effects of chamomile capsule on menstrual patterns and hormones and lipid parameters in woman with poly cystic ovarian syndrom

Early Phase 1

• Conditions: Polycystic Ovarian Syndrom.; Polycystic Ovarian Syndrome

• Registration Number: IRCT2014060217958N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 90

Inclusion Criteria

women whom have poly cystic ovarian syndrome that identify with gynecologist and endocrinologist? Having oligomenorrhea and second amenorrhea Exclusion criteria: having gastrointestinal? Liver?Kidney diseases?Convulsion?Allergic?Asthma?having the history of endometrial hyperplasia or breast cancer? taking the hormonal medicine from one month ago? having infertility? having AUB? Having allergic drug reaction? Can not continue taking medicine? High FSH hormone and early menopose Taking anti coagulant drugs.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
FSH. Timepoint: before and after of therapy. Method of measurement: sampling.;T Total. Timepoint: before and after of therapy. Method of measurement: sampling.;DHEAS. Timepoint: before and after of therapy. Method of measurement: sampling.;Menstural pattern. Timepoint: before and after of therapy. Method of measurement: questionnaire.;LH. Timepoint: before and after of therapy. Method of measurement: sampling.;TG. Timepoint: before and after of therapy. Method of measurement: sampling.;HDL. Timepoint: before and after of therapy. Method of measurement: sampling.